Spyre Therapeutics (SYRE) Q4 2019 Earnings

24FebExpected
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-16.5
-11.16
-5.82
-0.48

Details

Expected EPS
-0.67
Actual EPS
-16.25
Surprise EPS
-15.58
Surprise Percent
+2,325.37%

Description

Spyre Therapeutics (SYRE) has reported earnings of -16.25 per share for Q4 2019.

0 Comments

Share your thoughts